checkAd

    EQS-Adhoc  121  0 Kommentare Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

    Für Sie zusammengefasst
    • Dr Christian Wojczewski appointed as CEO of Evotec SE effective July 1, 2024.
    • Dr Mario Polywka, Interim CEO, to retire at end of June, not seeking re-election.
    • Wojczewski brings over 20 years of management experience to the role.

    EQS-Ad-hoc: Evotec SE / Key word(s): Personnel
    Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

    23-Apr-2024 / 20:38 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) announces the appointment of Dr Christian Wojczewski as Chief Executive Officer of the Company, effective 01 July 2024. Dr Wojczewski holds a degree in chemistry and has over 20 years of experience in various management positions, most recently as CEO of Mediq and at Linde Healthcare.

    Dr Mario Polywka, who has led Evotec as Interim CEO since 03 January 2024, will retire from his position at the end of June and will also not seek re-election for his dormant Supervisory Board mandate, which expires with the 2024 Annual General Meeting.

    – End of the ad hoc release –

    Contact: Volker Braun, EVP Head of Global Investor Relations & ESG, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49 (0)40 228 999 338, volker.braun@evotec.com



    End of Inside Information

    23-Apr-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: Evotec SE
    Manfred Eigen Campus / Essener Bogen 7
    22419 Hamburg
    Germany
    Phone: +49 (0)40 560 81-0
    Fax: +49 (0)40 560 81-222
    E-mail: info@evotec.com
    Internet: www.evotec.com
    ISIN: DE0005664809
    WKN: 566480
    Indices: MDAX, TecDAX
    Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Nasdaq
    EQS News ID: 1887561

     
    End of Announcement EQS News Service

    1887561  23-Apr-2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1887561&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e

    Evotec

    -1,45 %
    +5,60 %
    -30,51 %
    -26,28 %
    -41,65 %
    -71,58 %
    -55,43 %
    +173,20 %
    +294,58 %
    ISIN:DE0005664809WKN:566480


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer EQS-Ad-hoc: Evotec SE / Key word(s): Personnel Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer 23-Apr-2024 / 20:38 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, …

    Schreibe Deinen Kommentar

    Disclaimer